about
Chronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceOculo-Visual Dysfunction in Parkinson's Disease.Drug Interactions in Parkinson's Disease: Safety of Pharmacotherapy for Arterial HypertensionThe relationships between mild cognitive impairment and phenotype in Parkinson's diseaseTransitions in Parkinson's disease in primary care: protocol of a longitudinal mixed methods study.Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory DysfunctionSmall intestine dysfunction in Parkinson's disease."Gunslinger's gait": a new cause of unilaterally reduced arm swing.COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progMeasurement of Voluntary Cough Production and Airway Protection in Parkinson DiseaseClinical course and prognosis in patients with Gaucher disease and parkinsonismNewly Diagnosed Anemia Increases Risk of Parkinson's disease: A Population-Based Cohort StudyThe KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study GroupGastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Inflammation in Parkinson's disease: role of glucocorticoids.Nonmotor symptoms in sporadic versus familial forms of Parkinson's disease.The relevance of pre-motor symptoms in Parkinson's disease.Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.Systematic review on strength training in Parkinson's disease: an unsolved question.Mechanisms of Gene-Environment Interactions in Parkinson's Disease.Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls.Insomnia and somnolence in idiopathic RBD: a prospective cohort study.Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceThe BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease.Is there a Premotor Phase of Essential Tremor?Vertebrate food products as a potential source of prion-like α-synuclein.Recent advances in pharmacological research on Ecklonia species: a review.Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.Cognitive changes in prodromal Parkinson's disease: A review.Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults.
P2860
Q26748974-B1CE2F51-3F92-41D2-BC63-F956A9E2AA23Q26773064-2266CA8E-AFA6-4C98-A2F2-8B0C5C077C5DQ27691337-8D7126FD-7A4B-4BDD-AC7F-2DF9FEB31571Q28085554-0CC8BCC3-53A9-4F51-969C-28F719F7CF6FQ33917203-A070D4E3-98AE-4CFB-8ABD-EBCA3C79391DQ35691726-D43CDA6A-D746-4267-97AD-7A79D256361BQ36195000-B28FE54E-F77D-4AB0-8C73-B811960C4E2FQ36278083-D09DDAF8-016D-4E4F-A91B-49C235BD26F4Q36369299-0C3BF3E5-441F-47D0-857F-CA09638114B8Q36616565-E626C200-7E02-4187-98F7-A770C30203BCQ36626869-037771B0-EF64-452A-81CD-432BA03B6712Q36794066-37D8333F-A428-4FBA-88EE-39F1FCB2BAC8Q37093196-DC775A5D-CD24-40C5-A967-74A16BCF3E2DQ37338662-8656F4EC-754F-4384-B35E-D52700B10D32Q37516494-01FFCC96-8988-4BA6-A602-EB56AAF00284Q38425458-7EA21C3F-6AEB-4329-9552-8947A3D65991Q38430846-5F0D38A0-80C5-4C98-84FC-BAA0FEE4A1D7Q38594857-E9FF619B-8A9E-4D89-9304-F90CA1BFBF17Q38699508-8CB6717B-043E-47E9-8732-06CC44C045B8Q38780220-18B7612B-2BDE-41DF-878C-33CE2422753AQ39241699-AF204A54-B7D1-46AE-9312-827D680AC25AQ39247520-EB0C0B35-EBBB-4D27-ADFE-EC4B03354A64Q39393210-43AF083C-344D-40BF-9607-D4F1220A7A70Q39967268-B3D25C94-8EC0-4441-977A-79A7CE56DD2BQ41476211-F8BF6A5A-B7C0-4F8D-97E8-3E9C9FF4A7EFQ42138798-F82F563B-4FAD-45B6-A281-8AA28BA59927Q42268862-DE0DE68C-9F5D-4301-9996-E736B8E9B380Q42364022-1780240B-4EAE-4F96-92DA-BF4F49C239FFQ42373417-50D4108A-54F2-4028-835D-6B5765C70ACEQ46252338-06D914AC-ED45-42CA-9290-FD05806CAD0BQ46316469-DF32A56C-D6CC-4A47-AB30-B6ED72C2F236Q47111758-40AFE5AC-4680-499A-A218-57B595F1B666Q47366721-093D3FA6-2182-4244-BAF4-4D1006437F14Q47790326-01B3A2D9-EF30-4E68-A69F-140FFAA76D56Q47849289-A751BC34-1504-4999-B9E2-A2BAC7DD7D8BQ47860019-BC762726-D327-410C-BB08-20370E198282Q48030690-1EEA2FA8-CE7D-4942-AFA2-7E6FE1063748Q48129130-BC41C3B6-7749-4AA3-A351-E784523153C8Q48253622-E85E03A4-FB42-4CA3-B36E-461E572F2CEEQ48878610-FED34651-9852-4DA8-9F24-1A34D99D993E
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Premotor and nonmotor features of Parkinson's disease.
@ast
Premotor and nonmotor features of Parkinson's disease.
@en
Premotor and nonmotor features of Parkinson's disease.
@nl
type
label
Premotor and nonmotor features of Parkinson's disease.
@ast
Premotor and nonmotor features of Parkinson's disease.
@en
Premotor and nonmotor features of Parkinson's disease.
@nl
prefLabel
Premotor and nonmotor features of Parkinson's disease.
@ast
Premotor and nonmotor features of Parkinson's disease.
@en
Premotor and nonmotor features of Parkinson's disease.
@nl
P2860
P1476
Premotor and nonmotor features of Parkinson's disease.
@en
P2093
Jennifer G Goldman
Ron Postuma
P2860
P304
P356
10.1097/WCO.0000000000000112
P577
2014-08-01T00:00:00Z